Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX12 | P18054 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.42 |
| ▸ | ELANE | P08246 | 3/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CBS | P35520 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6142655 | 0.95 | ALOX12 (0.57) | ALOX12ALOX15PTPN1CYP19A1KCNH2 | |
| SCHEMBL6142614 | 0.92 | CYP19A1 (0.49) | ALOX12ALOX15PTPN1CYP19A1 | |
| SCHEMBL6143062 | 0.79 | CYP19A1 (0.63) | ALOX12ALOX15CYP19A1KCNH2TRPV1 | |
| Dihydrobiochanin A SCHEMBL30217535 | 0.78 | ALOX12 (0.67) | ALOX12ALOX15PTPN1CYP19A1KCNH2 | |
| SCHEMBL6142887 | 0.77 | CYP19A1 (0.68) | ALOX12ALOX15CYP19A1KCNH2TRPV1 | |
| SCHEMBL12825176 | 0.77 | ALOX12 (0.65) | ALOX12ALOX15PTPN1CYP19A1MEN1 | |
| SCHEMBL678189 | 0.77 | ALOX12 (0.65) | ALOX12ALOX15PTPN1CYP19A1MEN1 | |
| SCHEMBL29412620 | 0.77 | ALOX12 (0.65) | ALOX12ALOX15PTPN1CYP19A1MEN1 | |
| SCHEMBL15070036 | 0.76 | ALOX12 (0.60) | ALOX12ALOX15PTPN1CYP19A1KCNH2 | |
| SCHEMBL3956230 | 0.76 | ALOX12 (0.46) | ALOX12ALOX15PTPN1CYP19A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6951883-B2 | 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof | CHIESI FARMACEUTICI S.P.A. (IT) | 2005-10-04 | — | — | US | disclosed |
| EP-1229036-B1 | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof | CHIESI FARMA SPA (IT) | 2005-01-12 | — | — | EP | disclosed |
| US-20040106595-A1 | 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof | CHIESI FARMACEUTICI S.P.A. (IT) | 2004-06-03 | — | — | US | disclosed |
| EP-1355906-A1 | 2H-1-BENZOPYRAN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF | CHIESI FARMACEUTICI S.p.A. (IT) | 2003-10-29 | — | — | EP | disclosed |
| EP-1229036-A1 | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof | CHIESI FARMACEUTICI S.p.A. (IT) | 2002-08-07 | — | — | EP | disclosed |
| WO-2002059113-A1 | 2H-1-BENZOPYRAN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF | CHIESI FARMACEUTICI S.P.A. (IT) | 2002-08-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106595-A1 | 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof | CYP19A1, BRCA1, HPD | ALOX12 443/4885ALOX15 420/4885PTPN1 3256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.